I said, ‘You are going to take a lot of heat. I’m a polarizing figure,'” Sarah Palin admits she told Ron Duguay when they started dating.
The neuroendocrine carcinoma market is experiencing steady growth driven by rising disease prevalence and improved diagnostic capabilities. Advancements in targeted therapies and immunotherapies ...
Dr. Hope Rugo explains how antibody-drug conjugates like Datroway and Trodelvy are shifting the treatment landscape for ...
Zacks Investment Research on MSN
INCY wins EC approval for label expansion of oncology drug Zynyz
Incyte INCY recently announced that the European Commission has approved a label expansion of oncology drug Zynyz ...
Zacks Investment Research on MSN
Novocure's Optune Lua gets Japan reimbursement for NSCLC treatment
Novocure NVCR recently announced that Japan’s Ministry of Health, Labour and Welfare has approved reimbursement for Optune ...
On Wednesday, March 4, the content creator posted an emotional TikTok video after opening the latest report on her ...
�y!���0�����K#Du001a4�}��]�u0011ɷ�u000e�u0003��~u0019`� ...
Sacituzumab Govitecan Plus Pembrolizumab Shows Promise for Bladder Sparing in Muscle-Invasive Cancer
Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant ...
As Jessica Huffman underwent a double mastectomy and chemotherapy for invasive breast cancer two years ago, she felt mostly normal for most of the treatment. The exception was the loss of her long ...
Investigators evaluated the long-term impact of taxane chemotherapy on patient-reported neuropathy, balance problems, and falls among older breast cancer survivors.
Medicine has never been a polite topic for longtime Berkshire Hathaway Vice Chair Charlie Munger. The late investing legend spent decades dissecting markets, businesses and human ...
She ignored shoulder pain and fatigue at the age of 30. Months later, Amelia Bayer was given a Stage 4 breast cancer diagnosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results